vimarsana.com
Home
Live Updates
Off-Label Communications Back in the Spotlight at the FDA |
Off-Label Communications Back in the Spotlight at the FDA |
Off-Label Communications Back in the Spotlight at the FDA | Wilson Sonsini Goodrich & Rosati
For the first time in almost 10 years, the U.S. Food and Drug Administration (FDA) released a draft guidance related to certain communications by firms to healthcare providers (HCPs) of...
Related Keywords
Wilson Sonsini Goodrich Rosati ,
Drug Administration ,
Public Health Service ,
Wilson Sonsini Goodrich ,
From Firms ,
Unapproved Uses ,
Cleared Medical Products Questions ,
Answers Guidance ,
Medical Publications ,
Unapproved New Uses ,
Federal Food ,
Cosmetic Act ,
Public Health Service Act ,